- JP-listed companies
- COSMOS Pharmaceutical Corporation
- Income statement
COSMOS Pharmaceutical Corporation【JP:3349】Income statement
Market cap
¥611.4B
P/E ratio
19.5x
| 2011/05 | 2012/05 | 2013/05 | 2014/05 | 2015/05 | 2016/05 | 2017/05 | 2018/05 | 2019/05 | 2020/05 | 2021/05 | 2022/05 | 2023/05 | 2024/05 | 2025/05 | |
| Revenue | 237,174 | 279,021 | 329,313 | 371,825 | 408,466 | 447,273 | 502,732 | 557,999 | 611,137 | 684,403 | 726,424 | 755,414 | 827,697 | 964,989 | 1,011,390 |
| Cost of revenue | - | - | - | 301,268 | 330,391 | 360,420 | 402,688 | 447,681 | 489,353 | 549,419 | 581,313 | 603,966 | 658,979 | 776,683 | 798,109 |
| Gross profit | - | - | - | 70,557 | 78,074 | 86,853 | 100,044 | 110,317 | 121,784 | 134,984 | 145,111 | 151,447 | 168,718 | 188,305 | 213,281 |
| Gross margin (%) | - | - | - | ||||||||||||
| Operating income | - | - | - | 16,707 | 17,080 | 18,648 | 22,237 | 22,749 | 24,775 | 29,094 | 33,147 | 29,796 | 30,128 | 31,501 | 40,404 |
| Operating expenses | - | - | - | 53,849 | 60,993 | 68,205 | 77,806 | 87,568 | 97,008 | 105,890 | 111,964 | 121,651 | 138,589 | 156,804 | 172,877 |
| Income before tax | 11,071 | 14,517 | 16,787 | 18,193 | 19,028 | 20,691 | 24,591 | 25,255 | 27,292 | 31,562 | 35,835 | 32,861 | 33,086 | 34,299 | 43,160 |
| Provision for income taxes | - | - | - | 7,815 | 7,725 | 8,061 | 7,522 | 7,534 | 7,954 | 8,967 | 11,439 | 9,892 | 8,975 | 9,265 | 11,393 |
| Net income | 5,737 | 7,737 | 9,396 | 10,600 | 11,694 | 12,435 | 18,215 | 17,633 | 19,185 | 21,435 | 27,156 | 23,155 | 23,797 | 24,454 | 30,978 |
| Earnings per share | 289.79 | 390.78 | 474.58 | 535.41 | 590.63 | 628.05 | 919.99 | 890.59 | 968.97 | 541.3 | 685.8 | 584.76 | 600.96 | 617.22 | 390.86 |
| Dividend per share | 35 | 40 | 50 | 55 | 60 | 65 | 80 | 90 | 100 | 110 | 70 | 80 | 100 | 120 | 70 |